^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.

^e Tested in Ringer’s injection, lactated.

^f Lyophilized formulation tested.

^g Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^h Test performed using the formulation WITHOUT edetate disodium.

ⁱ Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^j Quinupristin and dalfopristin components combined.

^k Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^l Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^m Salt not specified.

ⁿ Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^o Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.